Black Cumin Oil Massages Ease Knee Arthritis Pain in Randomized Trial

Knee osteoarthritis is one of the most common and stubbornly disabling joint diseases in the world, and for millions of patients the options feel frustratingly narrow: painkillers with side effects, injections, physiotherapy, and eventually surgery. Now a randomized controlled trial from Türkiye suggests that an ancient remedy pressed from tiny black seeds may offer measurable relief. Researchers report that topical Nigella sativa oil, better known as black cumin or black seed oil, applied with a brief massage three times a day, significantly reduced pain, stiffness, and physical impairment in patients with knee osteoarthritis compared with a placebo oil, while also improving the range of motion in the affected joints.

The study, published in BMC Complementary Medicine and Therapies, was conducted by a team led by Sultan Çeçen of Hitit University together with colleagues from Hitit University Erol Olçok Training and Research Hospital and Erciyes University. The trial enrolled 75 patients diagnosed with knee osteoarthritis and randomly assigned them to three groups. One group received Nigella sativa oil, a second received a combination of naproxen and lidocaine gel, a topical formulation pairing a nonsteroidal anti-inflammatory drug with a local anesthetic, and a third received plain vaseline as a control. Each participant applied one milliliter of their assigned preparation to both knees with a two-minute massage, three times daily, for 21 days.

The design of the trial reflects a growing effort to test traditional remedies with the same rigor expected of pharmaceutical agents. Randomization was computer-generated, and the sample size was calculated in advance using the statistical power program G*Power, ensuring the study had a defined chance of detecting a real effect if one existed. The researchers measured outcomes with two well-established clinical tools: the Western Ontario and McMaster Universities Osteoarthritis Index, universally known as WOMAC, which quantifies pain, stiffness, and physical function through validated questionnaires, and direct measurement of knee joint range of motion, abbreviated KJROM, using goniometry. Results were reported as mean differences with 95 percent confidence intervals, the standard language of modern clinical evidence.

The findings were striking. Compared with patients who rubbed vaseline on their knees, those using black cumin oil experienced substantially greater reductions in WOMAC pain scores by day 21, with a between-group mean difference of minus 4.56 points and a confidence interval running from minus 7.99 to minus 1.13, a difference that was statistically significant at p equals 0.010. Stiffness improved as well, with a mean difference of minus 2.12 points and a confidence interval of minus 3.58 to minus 0.66, yielding p equals 0.005. Perhaps most importantly for daily living, physical function scores, the domain that captures how well patients can walk, climb stairs, and manage everyday tasks, dropped by a mean difference of minus 17.32 points, with a confidence interval from minus 28.61 to minus 6.03 and p equals 0.003.

The benefits extended beyond symptoms to joint mechanics. After the researchers adjusted for baseline measurements, the final knee joint range of motion values were significantly better in the black cumin oil group than in the vaseline group. The right knee showed an adjusted mean difference of 4.10 degrees, with a confidence interval of 1.83 to 6.36, and the left knee showed a difference of 5.84 degrees, with a confidence interval of 3.73 to 7.94, both highly significant at p less than 0.001. For patients whose stiffening joints gradually steal the ability to squat, kneel, or walk comfortably, a gain of several degrees of flexion is not a trivial statistic; it can translate into real functional differences in ordinary life.

Equally notable is the safety record. No adverse events were reported in any group during the three-week intervention, a clean profile that stands in contrast to the gastrointestinal, cardiovascular, and renal risks associated with long-term oral nonsteroidal anti-inflammatory drugs, the mainstay of pharmacological osteoarthritis treatment. The trial was approved by the Clinical Research Ethics Committee of the Kayseri City Hospital Traditional and Complementary Medicine Practices Center under the Turkish Ministry of Health, and all participants provided written and verbal informed consent. The study was registered in the Clinical Trials protocol registration system as NCT05541185, although the registration was retrospective, dated August 28, 2022, a methodological caveat that careful readers will notice.

Why might an oil pressed from the seeds of Nigella sativa, a flowering plant cultivated for millennia across the Middle East, South Asia, and North Africa, produce these effects? The seed and its oil contain thymoquinone, the compound most often credited with the plant’s pharmacological activity, along with thymohydroquinone, thymol, and a rich mixture of unsaturated fatty acids including linoleic and oleic acid. Laboratory and animal studies have repeatedly described anti-inflammatory and analgesic properties for these constituents, including modulation of inflammatory mediators and oxidative stress pathways that are also implicated in the cartilage degradation and synovial inflammation of osteoarthritis. The mechanical element of the intervention, a two-minute massage with each application, adds a second layer of plausibility, since massage itself is known to influence local circulation, muscle tension, and pain perception, though the vaseline control group received the identical massage, which helps isolate the specific contribution of the oil.

The trial’s comparative design adds an intriguing dimension. The naproxen and lidocaine gel arm was intended as an active comparator, representing a conventional topical pharmaceutical approach, yet the headline results reported in the paper compare the black cumin oil group against the vaseline placebo group. The authors frame Nigella sativa oil as an adjunct to standard medical treatment rather than a replacement for it, a positioning that matters clinically: patients in the study continued their usual care, and the oil was layered on top as a complementary therapy. This framing aligns with a broader shift in rheumatology and rehabilitation medicine toward multimodal management of osteoarthritis, where topical agents, exercise, weight management, and patient education are combined to delay or avoid more invasive interventions.

Caution, however, remains essential. The authors themselves emphasize that the sample size of 75 patients is relatively small and that the study carries methodological limitations, and they explicitly call for larger, adequately powered, multicenter randomized controlled trials to confirm the results. A three-week intervention cannot speak to long-term safety or to whether the benefits persist, accumulate, or fade after treatment stops. The retrospective trial registration, the absence of reported funding, and the open questions about blinding and adherence all warrant attention as the evidence base matures. Osteoarthritis research has a long history of promising early results from supplements and topical remedies that failed to hold up under larger, more rigorous scrutiny, so single trials, however encouraging, should be read as hypothesis-generating rather than practice-changing.

Still, the study is a welcome contribution to a field where patients desperately need more options. Knee osteoarthritis affects hundreds of millions of people worldwide, its prevalence rising with aging populations and obesity, and the gap between conservative care and joint replacement leaves many patients managing chronic pain for decades. If future trials confirm that a simple, inexpensive, topically applied seed oil can meaningfully reduce pain and improve joint mobility with no reported adverse effects, it could become a genuinely useful addition to the conservative management toolkit, particularly in settings where access to pharmacological treatment is limited or where patients prefer natural products. For now, the message from the Çorum researchers is measured but hopeful: black cumin oil, an ancient remedy subjected to a modern randomized trial, may be a promising complementary approach for knee osteoarthritis symptoms, and the scientific community now has a clear mandate to test that promise at scale.

Subject of Research: Topical Nigella sativa oil treatment for pain and physical function in knee osteoarthritis

Article Title: Effects of Nigella sativa oil on pain intensity and physical functions in patients with knee osteoarthritis: a comparative randomized controlled trial

Article References: Çeçen, S., Doğan, A. G., Taşcı, S., Şahin, S., & Doğan, M. (2026). Effects of Nigella sativa oil on pain intensity and physical functions in patients with knee osteoarthritis: a comparative randomized controlled trial. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05567-0

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05567-0

Keywords: knee osteoarthritis, Nigella sativa, black cumin oil, randomized controlled trial, WOMAC, pain management, complementary medicine, joint range of motion, thymoquinone, topical therapy, anti-inflammatory, physical function